CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ginwa Enterprise Group Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ginwa Enterprise Group Inc
No. 202 Science 4th Road, Hi-tech Zone
Phone: +86 2988336635p:+86 2988336635 XI'AN, SXI  710075  China Ticker: 600080600080
Business Summary
Ginwa Enterprise Group Inc is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company operates its businesses through three segments. The Pharmaceutical Industry segment is mainly engaged in the production of pharmaceuticals. The Company's products are divided into four series, including orthopedics, immunology, children's and general medicines, mainly covering chemicals, Chinese patent medicines, active pharmaceutical ingredient and health care products. The Hotel Industry segment is mainly engaged in the operation of hotels. The Pharmaceutical Commercial segment is mainly engaged in the sales of pharmaceuticals. The Company mainly operates its businesses in the domestic market.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries
7011 Hotels and motels
5812 Eating places

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board YajiangXing 54
Vice Chairman of the Board ChaoyangZhang 50 2/23/2022 6/1/2020
Chief Financial Officer YiwenHou 46 6/1/2014 6/1/2014
12 additional Officers and Directors records available in full report.

Business Names
Business Name
600080
Ginwa Enterprise (Group) Inc.

General Information
Number of Employees: 600 (As of 12/31/2022)
Outstanding Shares: 373,270,285 (As of 9/30/2023)
Shareholders: 36,402
Stock Exchange: SHA
Fax Number: +86 2981778626


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024